Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. - Wikidata - awgldk - TriplyDB

Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.

Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.

http://www.wikidata.org/entity/Q37187433

about

Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Nanoparticle-based drug delivery to the vagina: a review.How can we design better vaccines to prevent HIV infection in women?Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response.Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers.Modulation of HIV-1 immunity by adjuvants.Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.Microneedle patches for vaccination in developing countries.Recent advances in peptides for enhancing transdermal macromolecular drug delivery.Mucosal vaccine delivery: Current state and a pediatric perspective Microneedle arrays delivery of the conventional vaccines based on nonvirulent viruses.The success of microneedle-mediated vaccine delivery into skin.Dissolving Microneedle Patches for Dermal Vaccination Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection.Polymeric microneedles for transdermal protein delivery.Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate.Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans.

P2860

Q26778469-28E972C6-A3EF-434E-B24F-7ED85C464C0E Q27014949-4401AD3E-D8DB-4389-AEB1-9F55BD4FCCA8 Q30274995-52202097-436A-4954-BC2E-7DE94B9E69B0 Q30431343-D4AD606E-8BB8-4356-971A-12A7050F77DB Q34079533-015083ED-A44A-4474-B449-8F6753ED2C3C Q34449068-587826A8-B5B5-4A29-A542-396E6795A847 Q35132732-3AD09112-BD3D-41BB-A029-B32CC36BAC2C Q36881875-79B9BEA2-C370-4796-929B-8DBC70E15417 Q37197084-AF266487-CA3A-417C-97D3-E7B02BFA3B95 Q37682217-5E4A5F62-CECD-42A4-91F7-0E0BFA55B720 Q37698564-E7DB99BE-E852-494F-9C3D-E377DE02D5B8 Q38506865-8472775D-43C7-415C-AAFC-627C537B7641 Q38646712-D88EC35D-4201-4EEA-965A-461F6C729F03 Q38697294-0608B53F-1980-4664-A576-32EF9EDF3FDD Q38727453-4E5FAD02-F21F-4E10-BFEB-85B00D9BDDEF Q38770048-26E9AE2B-243B-46A0-91ED-C3EBA5E25AF0 Q38799509-1C7CE88B-1D7D-44E3-92EF-321527EB66F9 Q39440948-7920B104-EF47-45A4-9AE5-D9CAD75C1A01 Q47120596-59F6670A-03AD-4BB9-A7E1-EE8A259CD504 Q50169459-B4760180-6BF1-4A2D-8E9D-B389DEE3A52B Q50427910-EDBCF34C-DE0A-42B1-860C-1C32CBE1D4CB Q52657155-92FD63A3-C4C5-4637-B272-86A9978B4E4E

P2860

Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.

http://www.wikidata.org/entity/Q37187433

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 August 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Microneedle mediated intraderm ...... es mucosal boost inoculations.

@en

Microneedle mediated intraderm ...... es mucosal boost inoculations.

@nl

type

label

Microneedle mediated intraderm ...... es mucosal boost inoculations.

@en

Microneedle mediated intraderm ...... es mucosal boost inoculations.

@nl

prefLabel

Microneedle mediated intraderm ...... es mucosal boost inoculations.

@en

Microneedle mediated intraderm ...... es mucosal boost inoculations.

@nl

P1433

Q37187433-472A6115-6D3E-4638-A71B-C4C00C4B0B15

P1476

Q37187433-698AE9A3-E924-4233-A2A9-0302613ACD31

P2093

Q37187433-0281E57F-237E-4213-AF16-035885EF503A

Q37187433-181B79E0-BC55-435F-824D-241C67EE5A67

Q37187433-1F7201A0-77E8-4D31-A1AA-C466FA539F65

Q37187433-2CE1B401-5B94-4CCD-BE86-980D4FDB0555

Q37187433-6761B47C-FFE0-4244-AFD1-BBF7353D3BA2

Q37187433-800CC1A1-259D-4D51-A7AB-58216224172E

Q37187433-D542B674-37BB-413B-84A2-A52E6E2A0985

P2860

Q37187433-0324FAA0-C244-46FB-B581-7613966A07FB

Q37187433-0E8F15AF-85DF-49D6-9839-4C3C176913B6

Q37187433-0ECE684B-BBBA-4A81-BB05-6FD62453D72D

Q37187433-20EE9694-90E5-491F-AD5B-6A0C61F96C09

Q37187433-2A0DC763-874D-4C14-B260-6410978C57C5

Q37187433-422F496D-E412-426F-BAF6-33448FD02762

Q37187433-5514DC94-C0AD-4607-80FA-4B87DABD89E3

Q37187433-5BADBAF1-9DF1-4490-8CFF-CEAF01FFB601

Q37187433-7047D8DD-7982-41F4-A51D-6B16C54A6086

Q37187433-80B5E831-BA04-43D2-A688-00C490DEED1D

P304

Q37187433-4E54FF69-1CC7-46F6-9983-8A0F6B3AF554

P31

Q37187433-C5EAAB40-3FA2-4C52-A975-9B0FFD1A7F40

P356

Q37187433-448962D9-1B66-422B-A5DD-3D3380AAFBC8

P407

Q37187433-0A49F845-0189-456A-A294-9F1F37B20C5E

P433

Q37187433-76F4B593-A1C2-477D-9BA3-9571F9D639B4

P478

Q37187433-6D9E8621-EC59-4FC5-980A-D068F42193E4

P50

Q37187433-6590B4D5-8F3B-4071-B8F5-C55D0F421500

Q37187433-9DFC0826-568B-4362-88EC-1748D8A3D611

Q37187433-E6D2D63D-FB99-449E-B67C-B08865606B18

P577

Q37187433-39D85F56-EBE7-4632-9E37-FC1A0B15968A

P5875

Q37187433-D6CB46B9-C547-4C09-8585-91DA5F5E888A

P698

Q37187433-2B6BFC91-9188-42E1-AFC4-0F4A4D44331B

P921

Q37187433-78BC86B2-C025-4289-9E79-2C22D57AA185

P932

Q37187433-636D6096-B871-46B3-A18C-53E6284B1A48

P356

J.JCONREL.2012.07.039

P1433

Journal of Controlled Release

P1476

Microneedle mediated intraderm ...... mes mucosal boost inoculations

@en

P2093

Aditya Pattani

http://www.w3.org/2001/XMLSchema#string

Corona M Cassidy

http://www.w3.org/2001/XMLSchema#string

Helen O McCarthy

http://www.w3.org/2001/XMLSchema#string

Katarzyna Migalska

http://www.w3.org/2001/XMLSchema#string

Martin J Garland

http://www.w3.org/2001/XMLSchema#string

Rhonda M Curran

http://www.w3.org/2001/XMLSchema#string

Ryan F Donnelly

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines

Microneedle-based vaccines

Topical vaccination: the skin as a unique portal to adaptive immune responses.

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.

Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique

Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses

Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates

Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China.

Induction of mucosal immune responses in the human genital tract.

Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally

P304

529-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2012.07.039

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230825298

http://www.w3.org/2001/XMLSchema#string

P698

22960496

http://www.w3.org/2001/XMLSchema#string

P921

P932

3778941

http://www.w3.org/2001/XMLSchema#string